Comparison of Hyperbaric 0.5% Levobupivacaine and Hyperbaric 0.75% Ropivacaine for Intrathecal Use in Infraumbilical Surgeries: A Randomised Clinical Study

Introduction: Ropivacaine is a long-acting amide local anaesthetic agent and the pure S (-) enantiomer of propivacaine. It has been readily available as an isobaric solution for a long time. Recently, a hyperbaric solution has become available in the Indian market. Levobupivacaine is the pure S-enan...

Full description

Saved in:
Bibliographic Details
Main Authors: Tejash H Sharma, Jagrati Jain, Priya Kishnani, Richa Tailor, Sara Mary Thomas
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-02-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/20565/76171_CE[Ra1]__F(SS)_QC(PS_SS)_PF1(RI_SL)_redo_PFA(IS)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832574921468805120
author Tejash H Sharma
Jagrati Jain
Priya Kishnani
Richa Tailor
Sara Mary Thomas
author_facet Tejash H Sharma
Jagrati Jain
Priya Kishnani
Richa Tailor
Sara Mary Thomas
author_sort Tejash H Sharma
collection DOAJ
description Introduction: Ropivacaine is a long-acting amide local anaesthetic agent and the pure S (-) enantiomer of propivacaine. It has been readily available as an isobaric solution for a long time. Recently, a hyperbaric solution has become available in the Indian market. Levobupivacaine is the pure S-enantiomer of bupivacaine, which is safer than racemic bupivacaine in regional anaesthesia. It has less affinity and strength of depressant effects on myocardial and Central Nervous System (CNS) vital centers in pharmacodynamic studies, along with a superior pharmacokinetic profile. Aim: To compare the sensory and motor blockade, time of two-segment regression, time for rescue analgesia, haemodynamic effects and sedative effects between hyperbaric 0.5% levobupivacaine and hyperbaric 0.75% ropivacaine. Materials and Methods: This prospective, double-blinded and randomised clinical study was conducted in the Department of Anaesthesiology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre (a tertiary care institute), Sumandeep Vidyapeeth Deemed to be University, Piparia, Vadodara, Gujarat, India, from September 2023 to July 2024, with a sample size of 40 patients. Patients with American Society of Anaesthesiologists (ASA) I/II status were randomly allocated into two equal groups of 20 each. Group-R received 0.75% hyperbaric ropivacaine 3.5 mL+0.1 mL normal saline (total 3.6 mL) and Group-L received 0.5% hyperbaric levobupivacaine 3.5 mL+0.1 mL normal saline (total 3.6 mL). Data were recorded using MS Excel and analysed using Statistical Package for Social Sciences (SPSS version 22.0) software. The Student’s t-test was used for data comparison regarding the onset and duration of sensory and motor blockade, time of two-segment regression, time for rescue analgesia, haemodynamic stability and sedative effects between the study groups. Results: The mean age for Group-R was 45.00±7.1 years and Group-L 51.95±8.03 years. onset of sensory blockade at the T10 level and the onset of motor blockade in Group-R were slower than in Group-L (p-value <0.05). The time to two-segment regression was significantly faster in Group-R than in Group-L (p-value <0.05). The duration of sensory and motor blockade, as well as the time for rescue analgesia, was significantly prolonged in Group-L compared to Group-R (p-value <0.05). The sedative effects, arterial oxygen saturation (SpO2) and respiratory rate were comparable in both groups. Intraoperatively, haemodynamics were more stable in Group-R compared to Group-L. Conclusion: The present study implies that in haemodynamically unstable patients, 0.75% hyperbaric ropivacaine can provide a less complicated neuraxial blockade. In contrast, levobupivacaine offers a superior effect in terms of the duration of blockade and analgesia. This makes levobupivacaine useful for longer-duration surgeries, while ropivacaine is more suitable for shorter-duration procedures.
format Article
id doaj-art-3015f919ddcc4e358350499fea2fce60
institution Kabale University
issn 2249-782X
0973-709X
language English
publishDate 2025-02-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-3015f919ddcc4e358350499fea2fce602025-02-01T12:11:08ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-02-011902010510.7860/JCDR/2025/76171.20565Comparison of Hyperbaric 0.5% Levobupivacaine and Hyperbaric 0.75% Ropivacaine for Intrathecal Use in Infraumbilical Surgeries: A Randomised Clinical StudyTejash H Sharma0https://orcid.org/0000-0001-6656-0834Jagrati Jain1https://orcid.org/0009-0006-0611-940XPriya Kishnani2https://orcid.org/0000-0002-0075-8749Richa Tailor3https://orcid.org/0000-0006-9754-2210Sara Mary Thomas4https://orcid.org/0000-0002-6753-8118Professor, Department of Anaesthesiology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth (Deemed to be University), Piparia, Vadodara, Gujarat, India3rd Year Postgraduate Resident, Department of Anaesthesiology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth (Deemed to be University), Piparia, Vadodara, Gujarat, India.Associate Professor, Department of Anaesthesiology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth (Deemed to be University), Piparia, Vadodara, Gujarat, India.Assistant Professor, Department of Anaesthesiology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth (Deemed to be University), Piparia, Vadodara, Gujarat, India.Professor and Head, Department of Anaesthesiology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre, Sumandeep (Vidyapeeth Deemed to be University), Piparia, Vadodara, Gujarat, India.Introduction: Ropivacaine is a long-acting amide local anaesthetic agent and the pure S (-) enantiomer of propivacaine. It has been readily available as an isobaric solution for a long time. Recently, a hyperbaric solution has become available in the Indian market. Levobupivacaine is the pure S-enantiomer of bupivacaine, which is safer than racemic bupivacaine in regional anaesthesia. It has less affinity and strength of depressant effects on myocardial and Central Nervous System (CNS) vital centers in pharmacodynamic studies, along with a superior pharmacokinetic profile. Aim: To compare the sensory and motor blockade, time of two-segment regression, time for rescue analgesia, haemodynamic effects and sedative effects between hyperbaric 0.5% levobupivacaine and hyperbaric 0.75% ropivacaine. Materials and Methods: This prospective, double-blinded and randomised clinical study was conducted in the Department of Anaesthesiology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre (a tertiary care institute), Sumandeep Vidyapeeth Deemed to be University, Piparia, Vadodara, Gujarat, India, from September 2023 to July 2024, with a sample size of 40 patients. Patients with American Society of Anaesthesiologists (ASA) I/II status were randomly allocated into two equal groups of 20 each. Group-R received 0.75% hyperbaric ropivacaine 3.5 mL+0.1 mL normal saline (total 3.6 mL) and Group-L received 0.5% hyperbaric levobupivacaine 3.5 mL+0.1 mL normal saline (total 3.6 mL). Data were recorded using MS Excel and analysed using Statistical Package for Social Sciences (SPSS version 22.0) software. The Student’s t-test was used for data comparison regarding the onset and duration of sensory and motor blockade, time of two-segment regression, time for rescue analgesia, haemodynamic stability and sedative effects between the study groups. Results: The mean age for Group-R was 45.00±7.1 years and Group-L 51.95±8.03 years. onset of sensory blockade at the T10 level and the onset of motor blockade in Group-R were slower than in Group-L (p-value <0.05). The time to two-segment regression was significantly faster in Group-R than in Group-L (p-value <0.05). The duration of sensory and motor blockade, as well as the time for rescue analgesia, was significantly prolonged in Group-L compared to Group-R (p-value <0.05). The sedative effects, arterial oxygen saturation (SpO2) and respiratory rate were comparable in both groups. Intraoperatively, haemodynamics were more stable in Group-R compared to Group-L. Conclusion: The present study implies that in haemodynamically unstable patients, 0.75% hyperbaric ropivacaine can provide a less complicated neuraxial blockade. In contrast, levobupivacaine offers a superior effect in terms of the duration of blockade and analgesia. This makes levobupivacaine useful for longer-duration surgeries, while ropivacaine is more suitable for shorter-duration procedures.https://jcdr.net/articles/PDF/20565/76171_CE[Ra1]__F(SS)_QC(PS_SS)_PF1(RI_SL)_redo_PFA(IS)_PN(IS).pdfamide local anaestheticsanalgesiabelow naval levelhaemodynamic stabilityneuraxial block
spellingShingle Tejash H Sharma
Jagrati Jain
Priya Kishnani
Richa Tailor
Sara Mary Thomas
Comparison of Hyperbaric 0.5% Levobupivacaine and Hyperbaric 0.75% Ropivacaine for Intrathecal Use in Infraumbilical Surgeries: A Randomised Clinical Study
Journal of Clinical and Diagnostic Research
amide local anaesthetics
analgesia
below naval level
haemodynamic stability
neuraxial block
title Comparison of Hyperbaric 0.5% Levobupivacaine and Hyperbaric 0.75% Ropivacaine for Intrathecal Use in Infraumbilical Surgeries: A Randomised Clinical Study
title_full Comparison of Hyperbaric 0.5% Levobupivacaine and Hyperbaric 0.75% Ropivacaine for Intrathecal Use in Infraumbilical Surgeries: A Randomised Clinical Study
title_fullStr Comparison of Hyperbaric 0.5% Levobupivacaine and Hyperbaric 0.75% Ropivacaine for Intrathecal Use in Infraumbilical Surgeries: A Randomised Clinical Study
title_full_unstemmed Comparison of Hyperbaric 0.5% Levobupivacaine and Hyperbaric 0.75% Ropivacaine for Intrathecal Use in Infraumbilical Surgeries: A Randomised Clinical Study
title_short Comparison of Hyperbaric 0.5% Levobupivacaine and Hyperbaric 0.75% Ropivacaine for Intrathecal Use in Infraumbilical Surgeries: A Randomised Clinical Study
title_sort comparison of hyperbaric 0 5 levobupivacaine and hyperbaric 0 75 ropivacaine for intrathecal use in infraumbilical surgeries a randomised clinical study
topic amide local anaesthetics
analgesia
below naval level
haemodynamic stability
neuraxial block
url https://jcdr.net/articles/PDF/20565/76171_CE[Ra1]__F(SS)_QC(PS_SS)_PF1(RI_SL)_redo_PFA(IS)_PN(IS).pdf
work_keys_str_mv AT tejashhsharma comparisonofhyperbaric05levobupivacaineandhyperbaric075ropivacaineforintrathecaluseininfraumbilicalsurgeriesarandomisedclinicalstudy
AT jagratijain comparisonofhyperbaric05levobupivacaineandhyperbaric075ropivacaineforintrathecaluseininfraumbilicalsurgeriesarandomisedclinicalstudy
AT priyakishnani comparisonofhyperbaric05levobupivacaineandhyperbaric075ropivacaineforintrathecaluseininfraumbilicalsurgeriesarandomisedclinicalstudy
AT richatailor comparisonofhyperbaric05levobupivacaineandhyperbaric075ropivacaineforintrathecaluseininfraumbilicalsurgeriesarandomisedclinicalstudy
AT saramarythomas comparisonofhyperbaric05levobupivacaineandhyperbaric075ropivacaineforintrathecaluseininfraumbilicalsurgeriesarandomisedclinicalstudy